Sentence examples for therapy formulation from inspiring English sources

4. A feasibility, acceptability and clinical utility study of cognitive behaviour therapy formulation and treatment alongside joint patient management between the GP and therapist in regular attenders.

Current menopausal hormone therapy use at baseline, regardless of duration, significantly increased risk, but the baseline questionnaire did not query hormone therapy formulation or regimen.

The versatility of our UAN nanoparticles in both payload encapsulation and presentation of targeting ligands may facilitate developing a robust platform for evaluating various combinations of cancer drugs and molecular interactions toward developing effective cancer therapy formulations.

Estrogens have been used as contraceptive agents or as principal constituents of hormone replacement therapy formulations in postmenopausal women, 17β-estradiol being the most widely used molecule.

These findings may have implications for other hormone therapy formulations and routes of delivery.

The cognitive behaviour therapy formulations derived by the cognitive behaviour therapist will be analysed thematically in relation to the development of regular attendance.

Smokers were further asked whether they had heard about medication to help quit smoking, and if so which of the various nicotine replacement therapy formulations (gums, inhalers, patches) or other cessation drugs they had used.

There is some evidence that nicotine replacement therapies (NRT) formulations which act faster in relieving cravings for cigarettes are overall more effective at relieving withdrawal discomfort.

New mucoadhesive formulations were designed and studied in order to improve local vaginal therapy by increasing formulation retention prolonging thus drug mucosa contact time.

The BLISS study will define the CV safety profile of low-dose testosterone therapy in the formulation of LibiGel for postmenopausal women with HSDD, and the trial design may provide a paradigm for studies that aim to document long-term safety when the proposed outcome under study is an uncommon adverse event.

In an effort to improve efficiency of systemic delivery of modified mRNA for gene therapy, specific nanoparticle formulation using liposome-protamine-RNA (LPR) was suggested [61].